Bank Of New York Mellon Corp Cumberland Pharmaceuticals Inc Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.93 - $3.03 $38,296 - $60,124	-19,843 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$2.99 - $3.58 $1,109 - $1,328	-371 Reduced 1.84%	19,843 $60,000
Q1 2019 May 14, 2019	SELL	$5.06 - $6.5 $627 - $806	-124 Reduced 0.61%	20,214 $118,000
Q2 2018 Aug 06, 2018	SELL	$5.91 - $6.9 $26,595 - $31,050	-4,500 Reduced 18.12%	20,338 $125,000
Q1 2018 May 15, 2018	BUY	$6.62 - $7.12 $29,790 - $32,040	4,500 Added 22.13%	24,838 $166,000
Q4 2017 Feb 09, 2018	BUY	$6.79 - $7.96 $138,095 - $161,890	20,338	20,338 $150,000

1.97M

44.2K

Ticker CPIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 14,661,900
Market Cap $33.3M
Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.